SLC6A20 and COVID-19: The final finding of the present study was the association of rs2531743—located upstream of the SLC6A20 gene (also known as SIT1)—with COVID-19 susceptibility (as a combined effect with FURIN rs1894401) and neurological complications, which appeared in six months after COVID-19 recovery and was maintained within at least one year.